WADA publishes revised International Standard for Laboratories

The World Anti-Doping Agency (WADA) announced publication of the revised International Standard for Laboratories (ISL), which was approved by WADA’s Executive Committee (ExCo) on 15 May 2019 and will enter into force on 1 November 2019. The ISL is one of six International Standards that works in conjunction with the World Anti-Doping Code (Code) to bring harmonization among Anti-Doping Organizations across various technical areas. The main purpose of the ISL is to set out the requirements for laboratories … Continue reading WADA publishes revised International Standard for Laboratories

WADA amends Article 7.4 of the World Anti-Doping Code (Code)

World Anti-Doping Agency’s (WADA’s) Foundation Board decided to amend Article 7.4 of the World Anti-Doping Code (Code) to allow WADA-accredited Laboratories (Laboratories) to report Atypical Findings (ATFs) for the Prohibited Substance clenbuterol. Under the current version of Article 7.4 of the Code, Laboratories may only report analytical testing results for exogenous Prohibited Substances as Adverse Analytical Findings (AAFs) but not as ATFs, which does not allow for … Continue reading WADA amends Article 7.4 of the World Anti-Doping Code (Code)

Standard analyzer introduced by WADA at all laboratories approved for ABP controls

World Anti-Doping Agency (WADA) announced that it has coordinated the simultaneous introduction of identical hematology analyzers at all WADA-accredited and approved laboratories throughout the world to further enhance precision and consistency of doping controls carried out as part of the Athlete Biological Passport (ABP) program. These Sysmex XN-1000 automated hematology analyzers, which are operational globally from June 3, 2019 produce results that are more comparable and traceable over … Continue reading Standard analyzer introduced by WADA at all laboratories approved for ABP controls

Updates from WADA Compliance Review Committee

The independent Compliance Review Committee (CRC) of the World Anti-Doping Agency (WADA) held its latest meeting on 27-28 May 2019 in Copenhagen, Denmark, to discuss a number of issues related to compliance with the World Anti-Doping Code (Code). In particular, these included: An update on the analysis of the data retrieved from the Moscow Laboratory and the way forward for cases to be followed up by the relevant … Continue reading Updates from WADA Compliance Review Committee

THE COURT OF ARBITRATION FOR SPORT (CAS) AMENDS THE PERIODS OF INELIGIBILITY OF UKRAINIAN SPRINTERS OLHA ZEMLIAK AND OLESIA POVH

The Court of Arbitration for Sport (CAS) issued its decision in the appeal arbitration procedures between the Ukrainian sprinters Olha Zemliak and Olesia Povh (collectively, the Athletes), the Ukrainian Athletic Federation (UAF) and the World Anti-Doping Agency (WADA). The Athletes filed appeals at the CAS against the decisions issued by the UAF Executive Committee in February 2018 (the Challenged Decisions) in which they were found … Continue reading THE COURT OF ARBITRATION FOR SPORT (CAS) AMENDS THE PERIODS OF INELIGIBILITY OF UKRAINIAN SPRINTERS OLHA ZEMLIAK AND OLESIA POVH

Accreditation of Bucharest laboratory suspended by WADA

The World Anti-Doping Agency (WADA) announced the suspension of its accreditation of the Bucharest laboratory in Romania for a period of six months. This suspension was imposed due to a number of non-conformities with the International Standard for Laboratories (ISL), which on 29 November 2017, resulted in the laboratory being provisionally suspended. Since that date, disciplinary proceedings were carried out by an independent disciplinary committee mandated … Continue reading Accreditation of Bucharest laboratory suspended by WADA

WADA CODE : INTERNATIONAL STANDARD FOR THERAPEUTIC USE EXEMPTIONS

The International Standard for Therapeutic Use Exemptions is a mandatory International Standard developed as part of the World Anti-Doping Program. The purpose of the International Standard for Therapeutic Use Exemptions is to establish (a) the conditions that must be satisfied in order for a Therapeutic Use Exemption (or TUE) to be granted, permitting the presence of a Prohibited Substance in an Athlete’s Sample or the … Continue reading WADA CODE : INTERNATIONAL STANDARD FOR THERAPEUTIC USE EXEMPTIONS